Shilpa Medicare Ltd
NSE:SHILPAMED

Watchlist Manager
Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd
NSE:SHILPAMED
Watchlist
Price: 873.25 INR 5.87% Market Closed
Market Cap: 85.4B INR
Have any thoughts about
Shilpa Medicare Ltd?
Write Note

Intrinsic Value

The intrinsic value of one SHILPAMED stock under the Base Case scenario is 1 256.17 INR. Compared to the current market price of 873.25 INR, Shilpa Medicare Ltd is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SHILPAMED Intrinsic Value
1 256.17 INR
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Shilpa Medicare Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SHILPAMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SHILPAMED?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Shilpa Medicare Ltd

Provide an overview of the primary business activities
of Shilpa Medicare Ltd.

What unique competitive advantages
does Shilpa Medicare Ltd hold over its rivals?

What risks and challenges
does Shilpa Medicare Ltd face in the near future?

Summarize the latest earnings call
of Shilpa Medicare Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shilpa Medicare Ltd.

Provide P/S
for Shilpa Medicare Ltd.

Provide P/E
for Shilpa Medicare Ltd.

Provide P/OCF
for Shilpa Medicare Ltd.

Provide P/FCFE
for Shilpa Medicare Ltd.

Provide P/B
for Shilpa Medicare Ltd.

Provide EV/S
for Shilpa Medicare Ltd.

Provide EV/GP
for Shilpa Medicare Ltd.

Provide EV/EBITDA
for Shilpa Medicare Ltd.

Provide EV/EBIT
for Shilpa Medicare Ltd.

Provide EV/OCF
for Shilpa Medicare Ltd.

Provide EV/FCFF
for Shilpa Medicare Ltd.

Provide EV/IC
for Shilpa Medicare Ltd.

Show me price targets
for Shilpa Medicare Ltd made by professional analysts.

What are the Revenue projections
for Shilpa Medicare Ltd?

How accurate were the past Revenue estimates
for Shilpa Medicare Ltd?

What are the Net Income projections
for Shilpa Medicare Ltd?

How accurate were the past Net Income estimates
for Shilpa Medicare Ltd?

What are the EPS projections
for Shilpa Medicare Ltd?

How accurate were the past EPS estimates
for Shilpa Medicare Ltd?

What are the EBIT projections
for Shilpa Medicare Ltd?

How accurate were the past EBIT estimates
for Shilpa Medicare Ltd?

Compare the revenue forecasts
for Shilpa Medicare Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shilpa Medicare Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shilpa Medicare Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shilpa Medicare Ltd compared to its peers.

Compare the P/E ratios
of Shilpa Medicare Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shilpa Medicare Ltd with its peers.

Analyze the financial leverage
of Shilpa Medicare Ltd compared to its main competitors.

Show all profitability ratios
for Shilpa Medicare Ltd.

Provide ROE
for Shilpa Medicare Ltd.

Provide ROA
for Shilpa Medicare Ltd.

Provide ROIC
for Shilpa Medicare Ltd.

Provide ROCE
for Shilpa Medicare Ltd.

Provide Gross Margin
for Shilpa Medicare Ltd.

Provide Operating Margin
for Shilpa Medicare Ltd.

Provide Net Margin
for Shilpa Medicare Ltd.

Provide FCF Margin
for Shilpa Medicare Ltd.

Show all solvency ratios
for Shilpa Medicare Ltd.

Provide D/E Ratio
for Shilpa Medicare Ltd.

Provide D/A Ratio
for Shilpa Medicare Ltd.

Provide Interest Coverage Ratio
for Shilpa Medicare Ltd.

Provide Altman Z-Score Ratio
for Shilpa Medicare Ltd.

Provide Quick Ratio
for Shilpa Medicare Ltd.

Provide Current Ratio
for Shilpa Medicare Ltd.

Provide Cash Ratio
for Shilpa Medicare Ltd.

What is the historical Revenue growth
over the last 5 years for Shilpa Medicare Ltd?

What is the historical Net Income growth
over the last 5 years for Shilpa Medicare Ltd?

What is the current Free Cash Flow
of Shilpa Medicare Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shilpa Medicare Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shilpa Medicare Ltd

Current Assets 8.8B
Cash & Short-Term Investments 332.9m
Receivables 4B
Other Current Assets 4.5B
Non-Current Assets 22.2B
Long-Term Investments 462.7m
PP&E 16B
Intangibles 5.1B
Other Non-Current Assets 664.7m
Current Liabilities 6.9B
Accounts Payable 1.7B
Other Current Liabilities 5.2B
Non-Current Liabilities 5.9B
Long-Term Debt 5.6B
Other Non-Current Liabilities 297.3m
Efficiency

Earnings Waterfall
Shilpa Medicare Ltd

Revenue
11.8B INR
Cost of Revenue
-4.1B INR
Gross Profit
7.7B INR
Operating Expenses
-6.1B INR
Operating Income
1.6B INR
Other Expenses
-1.2B INR
Net Income
447.6m INR

Free Cash Flow Analysis
Shilpa Medicare Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Shilpa Medicare Ltd. reported Q1 FY 2025 revenues of INR 302 crores, a 15% year-on-year growth driven by its formulation business in emerging markets and licensing segments. The gross profit margin improved to 68%, up from 66% last year. The EBITDA surged 66% to INR 83 crores, lifting margins from 19% to 28%. Net debt reduced significantly from INR 912 crores to INR 514 crores. The company foresees continued momentum with efficient cost management and anticipates growth in the biologics and licensing areas alongside ongoing R&D investments and strategic partnerships.

What is Earnings Call?
Fundamental Scores

SHILPAMED Profitability Score
Profitability Due Diligence

Shilpa Medicare Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
45/100
Profitability
Score

Shilpa Medicare Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

SHILPAMED Solvency Score
Solvency Due Diligence

Shilpa Medicare Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Short-Term Solvency
45/100
Solvency
Score

Shilpa Medicare Ltd's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SHILPAMED Price Targets Summary
Shilpa Medicare Ltd

Wall Street analysts forecast SHILPAMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHILPAMED is 1 326 INR with a low forecast of 1 313 INR and a high forecast of 1 365 INR.

Lowest
Price Target
1 313 INR
50% Upside
Average
Price Target
1 326 INR
52% Upside
Highest
Price Target
1 365 INR
56% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SHILPAMED?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SHILPAMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shilpa Medicare Ltd Logo
Shilpa Medicare Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

85.4B INR

Dividend Yield

0%

Description

Shilpa Medicare Ltd. engages in the manufacturing of pharmaceutical product and wind power generation. The company is headquartered in Raichur, Karnataka. The firm is engaged in manufacturing active pharmaceutical ingredients (APIs), formulation and development service. The company is focused on new drug delivery systems, peptides/biotech products and specialty chemicals. The Company’s product range include oncology and non-oncology APIs, oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. The company supplies oncology/non-oncology APIs and intermediates. Its oncology APIs products include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India.

Contact

KARNATAKA
Raichur
#12-6-214/A1,, Hyderabad Road,
+918532238704
www.vbshilpa.com

IPO

1995-03-31

Employees

2 350

Officers

MD & Director
Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm
Chief Financial Officer
Mr. Alpesh Maheshkumar Dalal
VP of Projects & Operations and Whole-Time Director
Mr. Sharath Reddy Kalakota M.Pharma
Company Secretary & Compliance Officer
Ms. Ritu Tiwary
Chief Operating Officer of Formulations
Dr. Jayant Karajgi
President of Global R&D
Dr. Ganeshchandra Sonavane
Show More
Senior Vice President ? Domestic Formulations and Biologics
Mr. Rajeev Saxena
Senior Vice President of Formulation
Mr. Abhay Sapre
Executive Vice President ? Formulations for Small Molecules
Ms. Smita Holey
Vice President
Mr. Awez Mohinuddin Pathan
Show Less

See Also

Discover More
What is the Intrinsic Value of one SHILPAMED stock?

The intrinsic value of one SHILPAMED stock under the Base Case scenario is 1 256.17 INR.

Is SHILPAMED stock undervalued or overvalued?

Compared to the current market price of 873.25 INR, Shilpa Medicare Ltd is Undervalued by 30%.

Back to Top